Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-07-27

Clinical Trial Update: Vascular Function Intervention Trial in Sickle Cell Disease [Phase 2, Phase 3]

View source ↗

Summary

This entry reports an ongoing vascular function intervention trial in sickle cell disease, listed as Phase 2 and Phase 3, with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Sickle Cell Disease | Phase 2, Phase 3 | Status: UNKNOWN